Status:
RECRUITING
Validation of the REMINDER Dementia Risk Reduction Program
Lead Sponsor:
University of Coimbra
Collaborating Sponsors:
Fundação para a Ciência e a Tecnologia
Conditions:
Healthy Aging
Risk Reduction
Eligibility:
All Genders
60-75 years
Phase:
NA
Brief Summary
Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some R...
Detailed Description
The overarching tenet of this project is that, by providing a manualized multidomain intervention - REMINDER - that engages at risk individuals in the aims of this protocol, it can have a significant ...
Eligibility Criteria
Inclusion
- Age 60 or older
- CAIDE dementia risk score \>8
- Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED
- Free of physical disabilities that preclude participation in the study
- Willing to complete all study-related activities for 12 weeks
Exclusion
- Mild cognitive impairment or dementia;
- Presence of any neurological event in their medical history that could compromise actual cognition.
- Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria).
- Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group.
- Illiteracy
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05296980
Start Date
April 1 2022
End Date
October 1 2026
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Psychology and Educational Sciences
Coimbra, Portugal, 3002-115